trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Chondrosarcoma D002813 9 associated lipids
Cell Transformation, Viral D002472 26 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Cat Diseases D002371 12 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Carcinoma D002277 18 associated lipids
Breast Neoplasms D001943 24 associated lipids
Brain Neoplasms D001932 15 associated lipids
Body Weight D001835 333 associated lipids
Biliary Tract Neoplasms D001661 7 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Asthma D001249 52 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Alzheimer Disease D000544 76 associated lipids
Adrenoleukodystrophy D000326 29 associated lipids
Adenocarcinoma, Papillary D000231 2 associated lipids
Adenocarcinoma D000230 166 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Fetahu IS et al. Calcium-sensing receptor silencing in colorectal cancer is associated with promoter hypermethylation and loss of acetylation on histone 3. 2014 Int. J. Cancer pmid:24691920
Zhang YW et al. Integrated analysis of DNA methylation and mRNA expression profiling reveals candidate genes associated with cisplatin resistance in non-small cell lung cancer. 2014 Epigenetics pmid:24699858
Tu CY et al. Trichostatin A suppresses EGFR expression through induction of microRNA-7 in an HDAC-independent manner in lapatinib-treated cells. 2014 Biomed Res Int pmid:24707474
Yan YE et al. Prenatal nicotinic exposure suppresses fetal adrenal steroidogenesis via steroidogenic factor 1 (SF-1) deacetylation. 2014 Toxicol. Appl. Pharmacol. pmid:24709674
Zhu XJ et al. Novel tumor-suppressor gene epidermal growth factor-containing fibulin-like extracellular matrix protein 1 is epigenetically silenced and associated with invasion and metastasis in human gastric cancer. 2014 Mol Med Rep pmid:24718752
Drela K et al. Low oxygen atmosphere facilitates proliferation and maintains undifferentiated state of umbilical cord mesenchymal stem cells in an hypoxia inducible factor-dependent manner. 2014 Cytotherapy pmid:24726658
Hassan MK et al. Histone deacetylase inhibitors sensitize lung cancer cells to hyperthermia: involvement of Ku70/SirT-1 in thermo-protection. 2014 PLoS ONE pmid:24728004
Ma XH et al. Neuroprotective capabilities of TSA against cerebral ischemia/reperfusion injury via PI3K/Akt signaling pathway in rats. 2015 Int. J. Neurosci. pmid:24730998
Rafehi H et al. Vascular histone deacetylation by pharmacological HDAC inhibition. 2014 Genome Res. pmid:24732587
Poplutz MK et al. Regulation of the Interleukin-6 gene expression during monocytic differentiation of HL-60 cells by chromatin remodeling and methylation. 2014 Immunobiology pmid:24746556
Herr MJ et al. Tetraspanin CD9 modulates human lymphoma cellular proliferation via histone deacetylase activity. 2014 Biochem. Biophys. Res. Commun. pmid:24747564
Cheng X et al. Generation and characterization of gsuα:EGFP transgenic zebrafish for evaluating endocrine-disrupting effects. 2014 Toxicol. Appl. Pharmacol. pmid:24747804
Guo J et al. Effect of 5-aza-2'-deoxycytidine combined with trichostatin A on RPMI-8226 cell proliferation, apoptosis and DLC-1 gene expression. 2014 Zhongguo Shi Yan Xue Ye Xue Za Zhi pmid:24763005
Soler E and Grosveld F Targeting epigenetics to speed up repair. 2014 Cell Stem Cell pmid:24792110
Palii CG et al. Trichostatin A enhances vascular repair by injected human endothelial progenitors through increasing the expression of TAL1-dependent genes. 2014 Cell Stem Cell pmid:24792117
Peiffer L et al. Trichostatin A effectively induces apoptosis in chronic lymphocytic leukemia cells via inhibition of Wnt signaling and histone deacetylation. 2014 J. Cancer Res. Clin. Oncol. pmid:24793644
Guo W et al. Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma. 2014 Cancer pmid:24798237
Motevalli A et al. The effect of chemotherapeutic agents on telomere length maintenance in breast cancer cell lines. 2014 Breast Cancer Res. Treat. pmid:24807106
Meier BC and Wagner BK Inhibition of HDAC3 as a strategy for developing novel diabetes therapeutics. 2014 Epigenomics pmid:24811789
Skoge RH et al. Regulation of SIRT2-dependent α-tubulin deacetylation by cellular NAD levels. 2014 DNA Repair (Amst.) pmid:24814981
Wang Y et al. Inhibition of histone deacetylase in the basolateral amygdala facilitates morphine context-associated memory formation in rats. 2015 J. Mol. Neurosci. pmid:24829091
Bezecny P Histone deacetylase inhibitors in glioblastoma: pre-clinical and clinical experience. 2014 Med. Oncol. pmid:24838514
Zhang Y et al. Autophagy in pulmonary macrophages mediates lung inflammatory injury via NLRP3 inflammasome activation during mechanical ventilation. 2014 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:24838752
Kumafuji M et al. Mediator MED18 subunit plays a negative role in transcription via the CDK/cyclin module. 2014 Genes Cells pmid:24840924
Yang DH et al. Dynamic rearrangement of F-actin is required to maintain the antitumor effect of trichostatin A. 2014 PLoS ONE pmid:24846135
Kiliccioglu I et al. Apoptotic effects of proteasome and histone deacetylase inhibitors in prostate cancer cell lines. 2014 Genet. Mol. Res. pmid:24854658
Chan ST et al. Oral and intraperitoneal administration of quercetin decreased lymphocyte DNA damage and plasma lipid peroxidation induced by TSA in vivo. 2014 Biomed Res Int pmid:24868531
Alvarez AA et al. The effects of histone deacetylase inhibitors on glioblastoma-derived stem cells. 2015 J. Mol. Neurosci. pmid:24874578
Wang Y et al. Effects of histone deacetylase inhibition on the survival, proliferation and migration of Schwann cells, as well as on the expression of neurotrophic factors and genes associated with myelination. 2014 Int. J. Mol. Med. pmid:24888454
Smirnova L et al. MicroRNA profiling as tool for in vitro developmental neurotoxicity testing: the case of sodium valproate. 2014 PLoS ONE pmid:24896083
Ononye SN et al. Tropolones as lead-like natural products: the development of potent and selective histone deacetylase inhibitors. 2013 ACS Med Chem Lett pmid:24900743
Maleszewska M et al. The effects of selected inhibitors of histone modifying enzyme on C6 glioma cells. 2014 Pharmacol Rep pmid:24905315
Srirattana K et al. Effects of trichostatin A on In vitro development and DNA methylation level of the satellite I region of swamp buffalo (Bubalus bubalis) cloned embryos. 2014 J. Reprod. Dev. pmid:24909601
Felisbino MB et al. Changes in chromatin structure in NIH 3T3 cells induced by valproic acid and trichostatin A. 2014 J. Cell. Biochem. pmid:24913611
Thangavel J et al. Combinatorial therapy with acetylation and methylation modifiers attenuates lung vascular hyperpermeability in endotoxemia-induced mouse inflammatory lung injury. 2014 Am. J. Pathol. pmid:24929240
Balmer NV et al. From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. 2014 Arch. Toxicol. pmid:24935251
Ma H et al. HSPC117 is regulated by epigenetic modification and is involved in the migration of JEG-3 cells. 2014 Int J Mol Sci pmid:24941254
Hu Z and Wang J Histone deacetylase inhibitor induces the expression of select epithelial genes in mouse utricle sensory epithelia-derived progenitor cells. 2014 Cell Reprogram pmid:24945595
Yang XL et al. Effect of trichostatin A on CNE2 nasopharyngeal carcinoma cells--genome-wide DNA methylation alteration. 2014 Asian Pac. J. Cancer Prev. pmid:24969901
Wilson-Edell KA et al. RPL24: a potential therapeutic target whose depletion or acetylation inhibits polysome assembly and cancer cell growth. 2014 Oncotarget pmid:24970821
Bartling TR et al. Redox-sensitive gene-regulatory events controlling aberrant matrix metalloproteinase-1 expression. 2014 Free Radic. Biol. Med. pmid:24973648
Maldonado L et al. An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine. 2014 Oncotarget pmid:24980822
Liu H et al. The Smn-independent beneficial effects of trichostatin A on an intermediate mouse model of spinal muscular atrophy. 2014 PLoS ONE pmid:24984019
Ishihara K Eosinophil cell lines. 2014 Methods Mol. Biol. pmid:24986606
Xie L et al. Histone deacetylase inhibitors trichostatin A and vorinostat inhibit TGFβ2-induced lens epithelial-to-mesenchymal cell transition. 2014 Invest. Ophthalmol. Vis. Sci. pmid:24994865
Lee J et al. Therapeutic targeting of epigenetic components in amyotrophic lateral sclerosis (ALS). 2014 Curr. Med. Chem. pmid:25005187
Reeves ME et al. Evidence that RASSF1C stimulation of lung cancer cell proliferation depends on IGFBP-5 and PIWIL1 expression levels. 2014 PLoS ONE pmid:25007054
Scholpa NE et al. Epigenetic changes in p21 expression in renal cells after exposure to bromate. 2014 Toxicol. Sci. pmid:25015661
Uhlenbrock F et al. The NKG2D ligand ULBP2 is specifically regulated through an invariant chain-dependent endosomal pathway. 2014 J. Immunol. pmid:25024379
Ji Z et al. Integrating genomics and proteomics data to predict drug effects using binary linear programming. 2014 PLoS ONE pmid:25036040
Sun G et al. Insights into the lysine acetylproteome of human sperm. 2014 J Proteomics pmid:25038526
Huan YJ et al. Epigenetic modification agents improve genomic methylation reprogramming in porcine cloned embryos. 2014 J. Reprod. Dev. pmid:25047549
Tsuji M et al. Epigenetic regulation of resistance to emotional stress: possible involvement of 5-HT1A receptor-mediated histone acetylation. 2014 J. Pharmacol. Sci. pmid:25048113
Shi Q et al. [Inhibitory effect of trichostatin A on HepG2 cell proliferation and the mechanisms]. 2014 Nan Fang Yi Ke Da Xue Xue Bao pmid:25057056
Alsarraf O et al. Acetylation: a lysine modification with neuroprotective effects in ischemic retinal degeneration. 2014 Exp. Eye Res. pmid:25064603
Kondo Y et al. Histone deacetylase inhibitor valproic acid promotes the differentiation of human induced pluripotent stem cells into hepatocyte-like cells. 2014 PLoS ONE pmid:25084468
Wu TH et al. Melatonin prevents neonatal dexamethasone induced programmed hypertension: histone deacetylase inhibition. 2014 J. Steroid Biochem. Mol. Biol. pmid:25090636
Dubois-Pot-Schneider H et al. Inflammatory cytokines promote the retrodifferentiation of tumor-derived hepatocyte-like cells to progenitor cells. 2014 Hepatology pmid:25098666
Yoshida T et al. Kruppel-like factor 4 protein regulates isoproterenol-induced cardiac hypertrophy by modulating myocardin expression and activity. 2014 J. Biol. Chem. pmid:25100730
Helm D et al. Ion mobility tandem mass spectrometry enhances performance of bottom-up proteomics. 2014 Mol. Cell Proteomics pmid:25106551
Deng Y et al. [Expression of neprilysin gene is associated with methylation and histone modification on promoter in mouse neuroblastoma Neuro-2a cells]. 2014 Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi pmid:25108432
Zhang Q et al. Interferon regulatory factor 8 functions as a tumor suppressor in renal cell carcinoma and its promoter methylation is associated with patient poor prognosis. 2014 Cancer Lett. pmid:25109451
Vorrink SU et al. Epigenetic determinants of CYP1A1 induction by the aryl hydrocarbon receptor agonist 3,3',4,4',5-pentachlorobiphenyl (PCB 126). 2014 Int J Mol Sci pmid:25116688
Tomioka T et al. The histone deacetylase inhibitor trichostatin A induces neurite outgrowth in PC12 cells via the epigenetically regulated expression of the nur77 gene. 2014 Neurosci. Res. pmid:25128386
Kanski R et al. Histone acetylation in astrocytes suppresses GFAP and stimulates a reorganization of the intermediate filament network. 2014 J. Cell. Sci. pmid:25128567
Wei G et al. [Functional analysis of Oct4 promoter in Xuhuai goat]. 2014 Yi Chuan pmid:25143277
Saini M et al. Trichostatin A alters the expression of cell cycle controlling genes and microRNAs in donor cells and subsequently improves the yield and quality of cloned bovine embryos in vitro. 2014 Theriogenology pmid:25151601
Zohre S et al. Trichostatin A-induced apoptosis is mediated by Kruppel-like factor 4 in ovarian and lung cancer. 2014 Asian Pac. J. Cancer Prev. pmid:25169491
Lu HG et al. TET1 partially mediates HDAC inhibitor-induced suppression of breast cancer invasion. 2014 Mol Med Rep pmid:25175940
Svegliati S et al. Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis. 2014 Sci Signal pmid:25185156
Wang B et al. Reversion of trichostatin A resistance via inhibition of the Wnt signaling pathway in human pancreatic cancer cells. 2014 Oncol. Rep. pmid:25224651
Choi DC et al. MicroRNA-7 protects against 1-methyl-4-phenylpyridinium-induced cell death by targeting RelA. 2014 J. Neurosci. pmid:25232110
Wang BY et al. Epigenetic suppression of hippocampal BDNF mediates the memory deficiency induced by amyloid fibrils. 2014 Pharmacol. Biochem. Behav. pmid:25242807
Boucher J et al. Insulin and insulin-like growth factor 1 receptors are required for normal expression of imprinted genes. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:25246545
Han RF et al. Trichostatin A induces mesenchymal-like morphological change and gene expression but inhibits migration and colony formation in human cancer cells. 2014 Mol Med Rep pmid:25269990
Charni Chaabane S et al. PDGF-D expression is down-regulated by TGFβ in fibroblasts. 2014 PLoS ONE pmid:25280005
An JH et al. The expression of p21 is upregulated by forkhead box A1/2 in p53-null H1299 cells. 2014 FEBS Lett. pmid:25281925
Wei N et al. Oxidative stress diverts tRNA synthetase to nucleus for protection against DNA damage. 2014 Mol. Cell pmid:25284223
Shi QQ et al. Effect of trichostatin A on anti HepG2 liver carcinoma cells: inhibition of HDAC activity and activation of Wnt/β-Catenin signaling. 2014 Asian Pac. J. Cancer Prev. pmid:25292076
Toscano MG et al. SCL/TAL1-mediated transcriptional network enhances megakaryocytic specification of human embryonic stem cells. 2015 Mol. Ther. pmid:25292191
Tiernan AR et al. Trichostatin A affects the secretion pathways of beta and intestinal endocrine cells. 2015 Exp. Cell Res. pmid:25305500
Hou X et al. Histone deacetylase inhibitor regulates the balance of Th17/Treg in allergic asthma. 2016 Clin Respir J pmid:25307458
Mousai M et al. Effect of epigenetic modification with trichostatin A and S-adenosylhomocysteine on developmental competence and POU5F1-EGFP expression of interspecies cloned embryos in dog. 2015 Zygote pmid:25314965
Li G et al. Short-chain fatty acids enhance adipocyte differentiation in the stromal vascular fraction of porcine adipose tissue. 2014 J. Nutr. pmid:25320182
Xiong J et al. USP22 transcriptional activity is negatively regulated by the histone deacetylase inhibitor trichostatin A. 2014 Mol Med Rep pmid:25323692
Chahine MN et al. Nuclear pore rearrangements and nuclear trafficking in cardiomyocytes from rat and human failing hearts. 2015 Cardiovasc. Res. pmid:25341891
Xie M et al. Effects of 5-aza-2'-deoxycytidine and trichostatin A on high glucose- and interleukin-1β-induced secretory mediators from human retinal endothelial cells and retinal pigment epithelial cells. 2014 Mol. Vis. pmid:25352747
Saraf S et al. Ex vivo expansion of human mobilized peripheral blood stem cells using epigenetic modifiers. 2015 Transfusion pmid:25363624
Hao ZF et al. Activating transcription factor 3 interferes with p21 activation in histone deacetylase inhibitor-induced growth inhibition of epidermoid carcinoma cells. 2015 Tumour Biol. pmid:25371069
Nishida N et al. Identification of epigenetically inactivated genes in human hepatocellular carcinoma by integrative analyses of methylation profiling and pharmacological unmasking. 2014 Dig Dis pmid:25376292
Ying H et al. Pressure overload-induced cardiac hypertrophy response requires janus kinase 2-histone deacetylase 2 signaling. 2014 Int J Mol Sci pmid:25380525
Yang W et al. Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer's disease. 2014 Curr Alzheimer Res pmid:25387339
Sharma S et al. Histone deacetylase inhibitor, trichostatin A, improves learning and memory in high-fat diet-induced cognitive deficits in mice. 2015 J. Mol. Neurosci. pmid:25391764
Shao A et al. Enhancement of Autophagy by Histone Deacetylase Inhibitor Trichostatin A Ameliorates Neuronal Apoptosis After Subarachnoid Hemorrhage in Rats. 2016 Mol. Neurobiol. pmid:25399954
Lu HK et al. Ex vivo response to histone deacetylase (HDAC) inhibitors of the HIV long terminal repeat (LTR) derived from HIV-infected patients on antiretroviral therapy. 2014 PLoS ONE pmid:25409334
Saini M et al. Treatment of buffalo (Bubalus bubalis) donor cells with trichostatin A and 5-aza-2'-deoxycytidine alters their growth characteristics, gene expression and epigenetic status and improves the in vitro developmental competence, quality and epigenetic status of cloned embryos. 2016 Reprod. Fertil. Dev. pmid:25409339
Lv W et al. Histone deacetylase 1 and 3 regulate the mesodermal lineage commitment of mouse embryonic stem cells. 2014 PLoS ONE pmid:25412078
Ma X et al. Effect of LIV1 on the sensitivity of ovarian cancer cells to trichostatin A. 2015 Oncol. Rep. pmid:25420545
Wang X et al. Trichostatin A, a histone deacetylase inhibitor, reverses epithelial-mesenchymal transition in colorectal cancer SW480 and prostate cancer PC3 cells. 2015 Biochem. Biophys. Res. Commun. pmid:25434997
Wang J et al. Fungal metabolite myriocin promotes human herpes simplex virus-2 infection. 2015 Life Sci. pmid:25447452